Author: Matthew Nelson|| Date Published: December 16, 2019
McKesson (NYSE: MCK) has received a potential eight-year contract of undisclosed value to provide pharmaceutical supplies to outpatient clinics, medical centers and the Department of Veterans Affairs™ consolidated mail outpatient pharmacies.
Efforts under the contract are intended to support over 750 sites and seven CMOPs operated by the VA, the companysaid Thursday.
Contract work has a base period of two years starting in August and could extend to six more years if all options are exercised.
œWe are honored to once again be selected for the important responsibility of serving those who serve us and providing quality care for our veterans, said Brian Tyler, CEO at McKesson.
HawkEye 360, provider of space-based signals intelligence, has acquired Innovative Signal Analysis, a Dallas, Texas-based company manufacturing high-performance signal-processing technologies.…
The Defense Health Agency awarded a combined $8.07 billion in contracts to Humana Government Business, Evernorth Federal Services and Ipsos Public Affairs…
